AKT1 and central nervous system cancer: Wei and colleagues have recently reported that the CD133/PI3K/Akt signaling axis regulates glioma stem cell behavior, self-renewal, and tumorigenesis, as SRC binds to the cytoplasmic tail of CD133 and consequently activates the PI3K/Akt pathway [25].